Clinical Trial: AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL

U.S., Oct. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07215585) titled 'AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL' on Oct. 07.

Brief Summary: The purpose of this study is to measure the efficacy and safety of R-mini-CHOP x 2 followed by AZD0486 compared with R-mini-CHOP x 6 in elderly or unfit participants newly diagnosed with LBCL.

Study Start Date: Nov. 02

Study Type: INTERVENTIONAL

Condition: Large B-cell Lymphoma

Intervention: DRUG: AZD0486

Bispecific monoclonal IgG4 antibody

DRUG: R-mini-CHOP

Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AstraZeneca

Disclaimer: Curated by HT Syndication....